Dietary factors in the modulation of inflammatory bowel disease activity

MedGenMed Medscape General Medicine

Volumn 9, Issue 1, 2007, Pages

  Shah, Shinil ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOE VERA EXTRACT; ALPHA TOCOPHEROL; ALUMINUM SILICATE; APIGENIN; ASCORBIC ACID; AZATHIOPRINE; BOSWELLIA SERRATA EXTRACT; BROMELAIN; CALCITRIOL; CATECHIN; CHLOROPHYLL; CORTICOSTEROID; FRUCTOSE; GLUTAMINE; IMMUNOMODULATING AGENT; IRON; LACTOSE; LYCOPENE; MERCAPTOPURINE; MESALAZINE; MONOCLONAL ANTIBODY; PLACEBO; PROBIOTIC AGENT; RETINOL; SOMATOMEDIN C; SUCROSE; TITANIUM DIOXIDE;

ADJUVANT THERAPY; ALTERNATIVE MEDICINE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; CARBOHYDRATE DIET; CLINICAL TRIAL; COLOSTRUM; COMBINATION CHEMOTHERAPY; CROHN DISEASE; DIET THERAPY; DIETARY FIBER; DIETARY INTAKE; DISEASE ACTIVITY; DISEASE CONTROL; DRUG FEVER; DRUG MECHANISM; ELEMENTAL DIET; ENTERITIS; ENTEROCOCCUS FAECALIS; EVIDENCE BASED MEDICINE; EXPERIMENTAL DESIGN; FAT INTAKE; HEMOLYSIS; HUMAN; LACTOBACILLUS REUTERI; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDLINE; MONOTHERAPY; NONHUMAN; PATHOGENESIS; PLANT PRODUCT; PLANTAGO OVATA; REVIEW; SACCHAROMYCES BOULARDII; SCHISTOSOMA MANSONI; THERAPY EFFECT; ULCERATIVE COLITIS; URTICARIA; WHEATGRASS JUICE; METHODOLOGY;

COMPLEMENTARY THERAPIES; DIETARY FATS; HUMANS; INFLAMMATORY BOWEL DISEASES; PROBIOTICS;

EID: 33947731108     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. CCFA. Facts about the epidemiology of inflammatory bowel diseases (IBD). Available at: http://www.ccfa.org/about/press/epidemiologyfacts Accessed June 12, 2004.
2. Langmead L, Chitnis M, Rampton DS. Use of complementary therapies by patients with IBD may indicate psychosocial distress. Inflamm Bowel Dis. 2002;8:174-179. Abstract
3. Mahmud N, Weir DG. The urban diet and Crohn's disease: is there a relationship? Eur J Gastroenterol Hepatol. 2001;13:93-95.
4. Lomer MCE, Harvey RSJ, Evans SM, et al. Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn's disease. Eur J Gastroenterol Hepatol. 2001;13:101-106. Abstract
5. Philpott DJ, Viala J. Towards an understanding of the role of NOD2/ CARD15 in the pathogenesis of Crohn's disease. Best Pract Res Clin Gastroenterol. 2004;18:555-568. Abstract
6. Pizzorno JE, Murray MT. Textbook of Natural Medicine. 2nd ed. Philadelphia: Churchill Livingstone; 1999:112, 645-648, 746, 1341-1342, 1529.
7. Tsujikawa T, Andoh A, Fujiyama Y. Enteral and parenteral nutrition therapy for Crohn's disease. Curr Pharm Des. 2003;9:323-332. Abstract
8. Galandi D, Allgaier HP. Diet therapy in chronic inflammatory bowel disease: results from meta-analysis and randomized controlled trials. Schweiz Rundsch Med Prax. 2002;91:2041-2049. Abstract
9. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for inducing remission of Crohn's disease. Coch Database Syst Rev. 2001;(3):CD000542.
10. Burke A, Lichtenstein GR, Rombeau JL. Nutritional and metabolic advances in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 1998;1:387-390. Abstract
11. Reif S, Klein I, Lubin F, et al. Pre-illness dietary factors in inflammatory bowel disease. Gut. 1997;40:754-760. Abstract
12. Gottschall E. Breaking the Vicious Cycle: Intestinal Health Through Diet. Baltimore: Kirkton Press; 2000.
13. Tamboli CP, Neut C, Desreumaux P, et al. Dysbiosis in inflammatory bowel disease. Gut. 2004;53:1-4. Abstract
14. Parslow TG, Stites DP, Terr AI, et al. Medical Immunology. 10th ed. New York: McGraw-Hill; 2001:158-159, 194-195.
15. Hart AL, Stagg AJ, Kamm MA. Use of probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol. 2003;36:111-119. Abstract
16. Guslandi M, Giollo P, Testoni PA. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol. 2003;15:697-698. Abstract
17. Feldman M, Friedman LS, Sleisenger MH. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 7th ed. London: Elsevier; 2002:288.
18. Cabre E, Gassull MA. Nutritional and metabolic issues in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2003;6:569-576. Abstract
19. Bamba T, Shimoyama T, Sasaki M, et al. Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease: a randomized controlled trial. Eur J Gastroenterol Hepatol. 2003;15:151-157. Abstract
20. Cashman KD, Shanahan F. Is nutrition an aetiological factor for inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2003;15:607-613. Abstract
21. Rakel D. Integrative Medicine. New York: Elsevier; 2003:51.
22. Guarner F, Vilaseca J, Malagelada JR. Dietary manipulation in experimental inflammatory bowel disease. Agents Actions. 1992;Spec No:C10-4. Abstract
23. Yuceyar H, Ozutemiz O, Huseyinov A, et al. Is administration of n-3 fatty acids by mucosal enemas protective against trinitobenzene-induced colitis in rats? Prostaglandins Leukot Essent Fatty Acids. 1999;61:339-345.
24. Campbell JM, Fahey GC, Lichtensteiger CA, et al. An enteral formula containing fish oil, indigestible oligosaccharides, gum arabic and antioxidant affects plasma and colonic phospholipids fatty acid and prostaglandin profiles in pigs. J Nutr. 1997;127:137-145. Abstract
25. Empey LR, Jewell LD, Garg ML, et al. Fish oil enriched diet is mucosal protective against acetic acid induced colitis in rats. Can J Physiol Pharmacol. 1991;69:480-487. Abstract
26. Persson PG, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology. 1992;3:47-52. Abstract
27. Rodriguez-Cabezas ME, Galvez J, Concha A, et al. Dietary fiber down-regulates colonic tumor necrosis factor alpha and nitric oxide production in trinitrobenzenesulfonic acid induced colitic rats. J Nutr. 2002;132:3263-3211. Abstract
28. Fujita T, Sakurai K. Efficacy of glutamine enriched enteral nutrition in an experimental model of mucosal ulcerative colitis. Br J Surg. 1995;82:749-751. Abstract
29. Akobeng AK, Miller V, Stanton J, et al. Double blind randomized controlled trial of glutamine enriched polymeric diet in the treatment of active crohn's disease. J Pediatr Gastroenterol Nutr. 2000;30:78-84. Abstract
30. Oldenburg B, van Berge Henegouwen GP, Rennick D, et al. Iron supplementation affects the production of pro-inflammatory cytokines in IL-10 deficient mice. Eur J Clin Invest. 2000;30:505-510. Abstract
31. Reifen R, Matas A, Zeidel L, et al. Iron supplementation may aggravate inflammatory status of colitis in a rat model. Dig Dis Sci. 2000;45:394-397. Abstract
32. Carrier J, Aghdassi E, Cullen J, et al. Iron supplementation increased disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium induced colitis. J Nutr. 2002;132:3146-3150. Abstract
33. Sato K, Kanazawa A, Ota N, et al. Dietary supplementation of catechins and alpha-tocopherol accelerates the healing of trinitrobenzene sulfonic acid-induced ulcerative colitis in rats. J Nutr Sci Vitaminol. 1998;44:769-778. Abstract
34. Cantoma MT, Munsick C, Bemiss C, et. al. 1, 25 dihydrocholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr. 2000;130:2648-2652. Abstract
35. Deluca HF, Cantoma MT. Vitamin D: its role and uses in immunology. FASEB J. 2001;15:2579-2585. Abstract
36. Patel B, Schutte R, Sporns P, et al. Potato glycoalkaloids adversely affect intestinal permeability and aggravate inflammatory bowel disease. Inflamm Bowel Dis. 2002;8:340-346. Abstract
37. Procaccino F, Reinshagen M, Hoffmann P, et al. Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology. 1994;107:12-17. Abstract
38. Playford RJ, Macdonald CE, Johnson WS. Colostrum and milk-derived peptide growth factors for the treatment of gastrointestinal disorders. Am J Clin Nutr. 2000;72:5-14. Abstract
39. Howarth GS. Insulin-like growth factor-I and the gastrointestinal system: therapeutic indications and safety implications. J Nutr. 2003;133:2109-2112. Abstract
40. Howarth GS, Xian CJ, Read LC. Insulin-like growth factor-I partially attenuates colonic damage in rats with experimental colitis induced by oral dextran sulphate sodium. Scand J Gastroenterol. 1998;33:180-190. Abstract
41. Sinha A, Nightingale JMD, West KP, et. al. Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis. N Engl J Med. 2003;349:350-357. Abstract
42. Natural Medicines Comprehensive Database. Wheatgrass. Available at www.naturalmedicines.com. Accessed March 15, 2007.
43. Scientific abstracts: comprehensive nutrient review: apigenin overview. Available at: http://www.lef.org/abstracts/codex/apigenin_index.htm. Accessed: July 25, 2004.
44. Ben-Ayre E, Goldin E, Wengrower D, et al. Wheat grass juice in the treatment of active distal ulcerative colitis a randomized double-blind placebo-controlled trial. Scand J Gastroenterol. 2002;37:444-449. Abstract
45. Thomas DR. Vitamins in health and aging. Clin Geriatr Med. 2004;20:259-274. Abstract
46. Reifen R, Nissenkorn A, Matas Z, Bujanover Y. 5-ASA and lycopene decrease the oxidative stress and inflammation induced by iron in rats with colitis. J Gastroenterol. 2004;39:514-519. Abstract
47. Reifen R, Nur T, Matas Z, Halpern Z. Lycopene supplementation attenuates the inflammatory status of colitis in a rat model. Int J Vitam Nutr Res. 2001;71:347-351. Abstract
48. Nieves R, Jackson RT. Specific carbohydrate diet in treatment of inflammatory bowel disease. Tenn Med. 2004;97:407.
49. Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana JL, et al. Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish group for the study of crohn's disease and ulcerative colitis (GETECCU). Am J Gastroenterol. 1999;94:427-433. Abstract
50. Kanauchi O, Suga T, Tochihara M, et al. Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial. J Gastroenterol. 2002;37:67-72. Abstract
51. Kanauchi O, Mitsuyama K, Homma T, et al. Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial. Int J Mol Med. 2003;12:701-704. Abstract
52. Langmead L, Makins RJ, Rampton DS. Anti-inflammatory effects of aloe vera gel in human colorectal mucosa in vitro. Aliment Pharmacol Ther. 2004;19:521-527. Abstract
53. Langmead L, Feakins RM, Goldthorpe S, et al. Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther. 2004;19:739-747. Abstract
54. Kane S, Goldberg MJ. Use of bromelain for mild ulcerative colitis. Ann Intern Med. 2000;132:680.
55. Hale LP, Greer PK, Trinh CT, Gottfried MR. Treatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel disease. Clin Immunol. 2005;116:135-142. Abstract
56. Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R. Therapy of active Crohn disease with Boswellia serrata extract H 15. Z Gastroenterol. 2001;39:11-17.
57. Gupta I, Parihar A, Malhotra P, et al. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med. 2001;67:391-395. Abstract
58. Gupta I, Parihar A, Malhotra P, et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res. 1997;2:37-43. Abstract